3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Non-Hodgkin
14
Multiple Myeloma
13
Congenital Abnormalities
13
Leukemia, Lymphocytic, Chronic, B-Cell
11
Myelodysplastic Syndromes
9
Lymphoma, Mantle-Cell
9
Leukemia
9
Hodgkin Disease
9
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
7
Lymphoma
7
Waldenstrom Macroglobulinemia
6
Leukemia, Myeloid, Accelerated Phase
6
Sezary Syndrome
5
Recurrence
5
Mycosis Fungoides
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Large-Cell, Immunoblastic
5
Hematologic Neoplasms
5
Graft vs Host Disease
5
Burkitt Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Extranodal NK-T-Cell
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Anemia, Refractory, with Excess of Blasts
4
Neoplasms
3
Interventions
Microbial Collagenase
9
xiapex
5
Surgical Procedures, Operative
2
Sodium Chloride
2
Collagenases
2
Triamcinolone Acetonide
1
Transplantation
1
Tranexamic Acid
1
Therapeutics
1
Surveys and Questionnaires
1
Restraint, Physical
1
Radiotherapy
1
Oxycodone
1
Injections, Intra-Articular
1
Ibuprofen
1
High-Energy Shock Waves
1
Fasciotomy
1
Extracorporeal Shockwave Therapy
1
Enzymes
1
Dexamethasone
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Knee
1
Arthroplasty, Replacement, Elbow
1
Adrenal Cortex Hormones
1
Adalimumab
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Dupuytren Contracture
×
Transplantation
×
Clear all
NCT05067764
2026-04-23
REMEDY
Elsan
Phase NA
Recruiting
172 enrolled